Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A

Calcified Tissue International

Volumn 90, Issue 3, 2012, Pages 239-249

  Lukefahr, A L ^a   Frye, J B ^a   Wright, L E ^a   Marion, S L ^a   Hoyer, P B ^a   Funk, J L ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

4 Vinylcyclohexene diepoxide; Bone; Estradiol; Follicle stimulating hormone; Inhibin; Osteoporosis; Perimenopause

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN A; INHIBIN B; INHIBIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CLIMACTERIUM; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRUS CYCLE; FEMALE; FEMUR; HORMONE BLOOD LEVEL; LONGITUDINAL STUDY; NONHUMAN; OSTEOPOROSIS; OVARY FOLLICLE; PRIORITY JOURNAL; SENESCENCE; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RAT; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

ANIMALS; BONE DENSITY; DISEASE MODELS, ANIMAL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INHIBINS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84868324985     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9565-2     Document Type: Article

References (50)

1. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper J.L., Wark J.D. (1996) Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81: 3366-3371
2. Bainbridge KE, Sowers MF, Crutchfield M, Lin X, Jannausch M, Harlow S.D. (2002) Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 156: 410-417
3. Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley J.A., Sherman S., Greendale GA, Study of Women's health across the nation (2003) The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 14: 44-52
4. Sowers MR, Jannausch M, McConnell D, Little R, Greendale G.A., Finkelstein JS, Neer RM, Johnston J, Ettinger B. (2006) Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 91: 1261-1267
5. Grewal J, Sowers MR, Randolph JF Jr, Harlow SD, Lin X. (2006) Low bone mineral density in the early menopausal transition: role for ovulatory function. J Clin Endocrinol Metab 91: 3780-3785
6. Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo J.C., Johnston JM, Cauley JA, Danielson ME, Neer R.M. (2008) Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 93: 861-868
7. Sowers MR, Zheng H, Jannausch ML, McConnell D, Nan B, Harlow S., Randolph JF Jr (2010) Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 95: 2155-2162
8. Prior JC (2005) Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation. Endocrine 26: 297-300
9. Burger HG, Hale GE, Dennerstein L, Robertson D.M. (2008) Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 15: 603-612
10. Sowers MR, Zheng H, McConnell D, Nan B, Harlow S., Randolph JF Jr (2008) Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab 93: 3958-3964
11. Robertson DM, Hale GE, Jolley D, Fraser IS, Hughes CL, Burger H.G. (2008) Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J Clin Endocrinol Metab 94: 138-144
12. Vural F, Vural B, Yucesoy I, Badur S. (2005) Ovarian aging and bone metabolism in menstruating women aged 35-50 years. Maturitas 52: 147-153
13. Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D. (2006) Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 9: 1848-1854
14. Nicks KM, Perrien DS, Akel NS, Suva LJ, Gaddy D. (2009) Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, activin and inhibin. Mol Cell Endocrinol 310: 11-20
15. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou D.J., Zaidi S., Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A., Sairam MR, Kumar TR, Bo W, Braun J., Cardoso-Landa L, Schaffler MB, Moonga B.S., Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125: 247-260
16. Sun L, Zhang Z, Zhu LL, Peng Y, Liu X, Li J., Agrawal M, Robinson LJ, Iqbal J, Blair H.C., Zaidi M. (2010) Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun 394: 6-11
17. Ritter V, Thuering B, Saint Mezard P, Luong-Nguyen NH, Seltenmeyer Y., Junker U, Fournier B, Susa M., Morvan F. (2008) Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro. Calcif Tissue Int 82: 383-391
18. Drake MT, McCready LK, Hoey KA, Atkinson E.J., Khosla S. (2010) Effects of suppression of follicle stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab 95: 5063-5068
19. Ebeling PR (2010) What is the missing hormonal factor controlling menopausal bone resorption? J Clin Endocrinol Metab 95: 4864-4866
20. Nicks KM, Fowler TW, Akel NS, Perrien DS, Suva L.J., Gaddy D. (2010) Bone turnover across the menopause transition: the role of gonadal inhibins. Ann N Y Acad Sci 1192: 153-160
21. Iqbal J, Sun L, Zaidi M. (2010) FSH and bone 2010: evolving evidence. Eur J Endocrinol 163: 173-176
22. Rouach V, Katzburg S, Koch Y, Stern N, Somjen D. (2011) Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH. J Cell Biochem 112: 128-137
23. Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, Handelsman D.J., Seibel M.J. (2010) Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci USA 107: 22629-22634
24. Frye JB, Lukefahr AL, Wright LE, Marion SL, Hoyer P.B., Funk J.L. (2012) Modeling perimenopause in Rattus norvegicus (Sprague Dawley) by chemical manipulation of the transition to ovarian failure. Comp Med (in press)
25. Vom Saal F.S., Finch CE, Nelson J.F. (1994) Natural history and mechanisms of reproductive aging in humans, laboratory rodents, and other selected vertebrates. In: Knobil K, Neill JD (eds) The physiology of reproduction, 2nd edn. Raven Press, New York, pp 1213-1314
26. Peluso JJ, Steger RW, Huang H, Meites J. (1979) Pattern of follicular growth and steroidogenesis in the ovary of aging cycling rats. Exp Aging Res 5: 319-333
27. Huang HH, Meites J. (1975) Reproductive capacity of aging female rats. Neuroendocrinology 17: 289-295
28. Butcher RL, Page R.D. (1981) Role of the aging ovary in cessation of reproduction. In: Schwartz NB, Hunzicker-Dunn M (eds) Dynamics of ovarian function. Raven Press, New York, pp 253-270
29. Dannaker CJ (1988) Allergic sensitization to a non-bisphenol A epoxy of the cycloaliphatic class. J Occup Med 30: 641-643
30. Haas JR, Christian PJ, Hoyer P.B. (2007) Effects of impending ovarian failure induced by 4-vinylcyclohexene diepoxide on fertility in C57BL/6 female mice. Comp Med 57: 443-449
31. Mayer LP, Devine PJ, Dyer CA, Hoyer P.B. (2004) The follicle-deplete mouse ovary produces androgen. Biol Reprod 71: 130-138
32. Wright LE, Christian PJ, Rivera Z, Van Alstine WG, Funk JL, Bouxsein ML, Hoyer P.B. (2008) Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice. J Bone Miner Res 23: 1296-1303
33. Chapman SC, Woodruff T.K. (2003) Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin. Endocrinology 144: 5640-5649
34. Goldman JM, Murr AS, Cooper R.L. (2007) The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B 80: 84-97
35. Mayer LP, Pearsall NA, Christian PJ, Devine PJ, Payne C.M., McCuskey MK, Marion SL, Sipes IG, Hoyer P.B. (2002) Longterm effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod Toxicol 16: 775-781
36. LeFevre J, McClintock M.K. (1988) Reproductive senescence in female rats: a longitudinal study of individual differences in estrous cycles and behavior. Biol Reprod 38: 780-789
37. Iwaniec UT, Samnegård E, Cullen DM, Kimmel D.B. (2001) Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Bone 29: 352-360
38. Griffin MG, Kimble R, Hopfer W, Pacifici R. (1993) Dual-energy X-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss. J Bone Miner Res 8: 795-800
39. Rabii J, Ganong W.F. (1976) Responses of plasma "estradiol," and plasma LH to ovariectomy, ovariectomy plus adrenalectomy, and estrogen injection at various ages. Neuroendocrinology 20: 270-281
40. Kalu DN, Liu CC, Salerno E, Hollis B, Echon R, Ray M. (1991) Skeletal response of ovariectomized rats to low and high-doses of 17 beta-estradiol. Bone Miner 14: 175-187
41. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R. (1993) Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91: 2479-2487
42. Lea CK, Flanagan A.M. (1998) Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat. Am J Physiol 274: 328-335
43. Zhao H, Tian Z, Hao J, Chen B. (2005) Extragonadal aromatization increases with time after ovariectomy in rat. Reprod Biol Endocrinol 3: 6
44. Turner RT, Vandersteenhoven JJ, Bell N.H. (1987) The effects of ovariectomy and 17b-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2: 115-122
45. Wronski TJ, Cintrón M, Doherty AL, Dann L.M. (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123: 681-686
46. Kenny HA, Woodruff T.K. (2006) Follicle size class contributes to distinct secretion patterns of inhibin isoforms during the rat estrous cycle. Endocrinology 147: 51-60
47. Jih MH, Lu JK, Wan YJ, Wu T.C. (1993) Inhibin subunit gene expression and distribution in the ovaries of immature, young adult, middle-aged, and old female rats. Endocrinology 132: 319-326
48. Wronski TJ, Dann LM, Scott KS, Cintrón M (1989) Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45: 360-366
49. Stenvers KL, Findlay J.K. (2010) Inhibins: from reproductive hormones to tumor suppressors. Trends Endocrinol Metab 21: 174-180
50. Reame NE, Lukacs JL, Olton P, Ansbacher R, Padmanabhan V. (2007) Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition. Fertil Steril 88: 1003-1005